Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1997 1
2000 2
2001 3
2002 4
2003 6
2004 15
2005 19
2006 24
2007 33
2008 36
2009 36
2010 39
2011 60
2012 64
2013 67
2014 103
2015 136
2016 160
2017 191
2018 225
2019 259
2020 248
2021 267
2022 200
2023 242
2024 88

Text availability

Article attribute

Article type

Publication date

Search Results

2,174 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Leone
Page 1
The Importance of Nutrition in Hypertension.
Fantin F, Macchi F, Giani A, Bissoli L. Fantin F, et al. Nutrients. 2019 Oct 21;11(10):2542. doi: 10.3390/nu11102542. Nutrients. 2019. PMID: 31640287 Free PMC article.
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.
Tan AR, Im SA, Mattar A, Colomer R, Stroyakovskii D, Nowecki Z, De Laurentiis M, Pierga JY, Jung KH, Schem C, Hogea A, Badovinac Crnjevic T, Heeson S, Shivhare M, Kirschbrown WP, Restuccia E, Jackisch C; FeDeriCa study group. Tan AR, et al. Lancet Oncol. 2021 Jan;22(1):85-97. doi: 10.1016/S1470-2045(20)30536-2. Epub 2020 Dec 21. Lancet Oncol. 2021. PMID: 33357420 Clinical Trial.
BACKGROUND: A subcutaneous formulation of pertuzumab and trastuzumab with recombinant human hyaluronidase in one ready-to-use, fixed-dose combination vial (pertuzumab, trastuzumab, and hyaluronidase-zzxf) was approved by the US Food and Drug Administration (FDA) on June 29, 2020. …
BACKGROUND: A subcutaneous formulation of pertuzumab and trastuzumab with recombinant human hyaluronidase in one ready-to-use, fixed-dose co …
PFAPA syndrome: a review on treatment and outcome.
Vanoni F, Theodoropoulou K, Hofer M. Vanoni F, et al. Pediatr Rheumatol Online J. 2016 Jun 27;14(1):38. doi: 10.1186/s12969-016-0101-9. Pediatr Rheumatol Online J. 2016. PMID: 27349388 Free PMC article. Review.
Debating Euthanasia and Physician-Assisted Death in People with Psychiatric Disorders.
Grassi L, Folesani F, Marella M, Tiberto E, Riba MB, Bortolotti L, Toffanin T, Palagini L, Belvederi Murri M, Biancosino B, Ferrara M, Caruso R. Grassi L, et al. Curr Psychiatry Rep. 2022 Jun;24(6):325-335. doi: 10.1007/s11920-022-01339-y. Epub 2022 Jun 9. Curr Psychiatry Rep. 2022. PMID: 35678920 Free PMC article. Review.
The "Federica" Hand.
Esposito D, Savino S, Andreozzi E, Cosenza C, Niola V, Bifulco P. Esposito D, et al. Bioengineering (Basel). 2021 Sep 21;8(9):128. doi: 10.3390/bioengineering8090128. Bioengineering (Basel). 2021. PMID: 34562951 Free PMC article.
The activation speed (about half a second) is high enough to allow the user to grab objects on the fly. The cost of the device is less then 100 USD. The "Federica" hand has proved to be a lightweight, low-cost and extremely efficient prosthesis. It is now available as an o …
The activation speed (about half a second) is high enough to allow the user to grab objects on the fly. The cost of the device is less then …
Primates unleashed.
Amici F, Liebal K. Amici F, et al. Behav Brain Sci. 2023 Feb 17;46:e2. doi: 10.1017/S0140525X22000747. Behav Brain Sci. 2023. PMID: 36799038
2,174 results